Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCB1 | P08183 | 3/20 | 0.35 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.33 |
| ▸ | MAOA | P21397 | 1/20 | 0.32 |
| ▸ | ACHE | P22303 | 1/20 | 0.32 |
| ▸ | PTPRB | P23467 | 1/20 | 0.30 |
| ▸ | CA12 | O43570 | 1/20 | 0.30 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
| ▸ | CA9 | Q16790 | 1/20 | 0.30 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28627303 | 1.00 | ABCB1 (0.35) | ABCB1HRH3MAOAACHEPTPRB | |
| SCHEMBL17728802 | 1.00 | ABCB1 (0.35) | ABCB1HRH3MAOAACHEPTPRB | |
| SCHEMBL12880125 | 1.00 | ABCB1 (0.35) | ABCB1HRH3MAOAACHEPTPRB | |
| SCHEMBL17728801 | 1.00 | ABCB1 (0.35) | ABCB1HRH3MAOAACHEPTPRB | |
| SCHEMBL31232627 | 1.00 | ABCB1 (0.35) | ABCB1HRH3MAOAACHEPTPRB | |
| SCHEMBL17739798 | 1.00 | ABCB1 (0.35) | ABCB1HRH3MAOAACHEPTPRB | |
| SCHEMBL17728803 | 1.00 | ABCB1 (0.35) | ABCB1HRH3MAOAACHEPTPRB | |
| SCHEMBL22045464 | 0.90 | ABCB1 (0.44) | ABCB1MAOAPTPRB | |
| SCHEMBL20586403 | 0.90 | ABCB1 (0.44) | ABCB1MAOAPTPRB | |
| SCHEMBL20529469 | 0.90 | ABCB1 (0.44) | ABCB1MAOAPTPRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113454097-A | Tubulysins and protein-tubulysin conjugates | 里珍纳龙药品有限公司 | 2021-09-28 | — | — | CN | disclosed |